A pediatric-focused review of the performance incentive literature

Alyna T Chien1, Rena M Conti, Harold A Pollack

  • 1Section of Advanced Pediatric Health Services, Department of Pediatrics, University of Chicago, Chicago, Illinois 60637, USA. alyna_chien@yahoo.com

Insights

Performance incentives show limited effectiveness in improving pediatric healthcare. Evidence is scarce, with no studies examining unintended consequences or risk adjustment strategies for children.

Area of Science:

  • Pediatric Healthcare Quality Improvement
  • Health Services Research
  • Incentive Program Evaluation

Background:

  • Performance incentives are increasingly used in healthcare to improve quality.
  • Limited research exists on their effectiveness specifically within pediatrics.
  • Understanding these incentives is crucial for optimizing child health outcomes.

Purpose of the Study:

  • To review the existing literature on performance incentives in pediatrics.
  • To compare pediatric incentive literature with adult healthcare and educational programs.
  • To identify critical knowledge gaps in pediatric performance incentive research.

Main Methods:

  • Systematic review of empirical studies on pediatric performance incentives.
  • Analysis of the scope and focus of the pediatric literature.
  • Comparison with adult medicine and school/teacher accountability literature.

Main Results:

  • The pediatric performance incentive literature is limited, comprising only five empirical studies.
  • Performance incentives alone have not demonstrated effectiveness in improving pediatric healthcare.
  • A significant lack of research exists on unintended consequences and risk adjustment in pediatric settings.

Conclusions:

  • Pediatricians should be aware of the limitations of current evidence regarding performance incentives.
  • Skepticism is warranted regarding the optimistic claims about improving pediatric healthcare quality.
  • Further research is needed to explore potential negative effects and optimization strategies.
Abstract

Related Concept Videos

Incentive Theory: Pull Theory of Motivation01:18

Incentive Theory: Pull Theory of Motivation

Incentive theory, or the "pull theory" of motivation, suggests that external rewards primarily drive behavior. Individuals are motivated to engage in activities when they anticipate a desirable outcome. This is why people often work hard for promotions or study intensively to achieve high grades. These incentives can be tangible, physical rewards such as money or promotions, or intangible, non-physical rewards like praise and social recognition.
The theory differentiates between intrinsic and...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...